Hansjorg Hauselmann

Hirslanden Klinik Im Park
Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Post-fracture care and predictors of anti-osteoporotic treatment in Switzerland: a nationwide health claims analysis.

The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland.

Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.

Showing 1-10 of 10

Last Updated: 09/26/2026